维普中文期刊产品整合服务
33篇 您的检索式:作者名="Van CRUIJSEN H"
    题名 作者 年代 出处 被引量
1Epidermal growth faetor receptor and angiogenesis: Opportunities for combined anticancer strategies显示文摘van Cruijsen H Giaccone G Hoekman K 2005Int J Cancer2005,117,6:1
2Epidermal growth factor receptor and angiogenesis : Opportunities for combined anticancer strategies 显示文摘van Cruijsen H Giaccone G Hoekman K 2005Int J Cancer2005,117,6:1
3Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies显示文摘van Cruijsen H Giaccone G Hoekman K 2005Int J Cancer2005,117,6:1
4Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir显示文摘Razonable RR van Cruijsen H Brown RA 2003J Infect Dis2003,187,11:1
5The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients显示文摘Meijerink MR van Cruijsen H Hoekman K 2006Eur Radiol2006,17,7:1
6Glioblastoma- induced inhibition of Langerhans cell differentiation from CD34 ( + ) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibition 显示文摘van Cruijsen H Oosterhoff D Lindenberg JJ 2011Immunotherapy2011,3,9:1
7Epidermal growth factor receptor and angiogenesis : Opportunities for combined anticancer strategies 显示文摘van Cruijsen H Giaccone G Hoekman K 2005Int J Cancer2005,117,6:1
8Dynamics of cytomegalovirus replication during preemotive therapy with oral ganciclovir 显示文摘Razonable RR Van Cruijsen H Brown RA 2003J Infect Dis2003,187,11:1
9Epidermal growth factor receptor and angiogenesis: opportunities for combined anticancer strategies显示文摘van Cruijsen H Giaceone G Hoekman K 2005Int J Cancer2005,117,6:1
10Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendriticcell infiltration and microvessel density in non-small cell lung cancer显示文摘van Cruijsen H Ruiz MG van der Valk P 2009BMC Cancer2009,9,:1
11Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CDIc+ dendritic cell frequency predicts progression-free survival 显示文摘van Cruijsen H Van der Veldt AA Vroling L 2008Clin Cancer Res2008,14,18:1
12Epidermal Growth Factor Receptor and Angiogenesis:Opportunities for Combined Anticancer Strategies显示文摘van Cruijsen H Giaccone G Hoekman K 2005Int J Cancer2005,117,6:1
13Epidermal growth factor receptor and angiogenesis Opportunities for combined anticancer strategies 显示文摘van Cruijsen H Giaccone G Hoekman K 2005Int J Cancer2005,117,6:1
14Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir显示文摘Razonabale RR Van Cruijsen H Brown RA 2003J Infect Dis2003,187,11:1
15Epidermal growth factor receptor and angiogenesis:opportunities for combined anticancer strategies显示文摘VAN CRUIJSEN H GIACCONE G HOEKMAN K 2005Int J Cancer2005,117,6:1
16Prostate cancer detection at low prostate spe- cific antigen 显示文摘Schroder F H Van der Cruijsen - Koeter I de Koning H J 2000J urol2000,163,3:1
17Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir显示文摘Razonable R R van Cruijsen H Brown R A 2003J Infect Dis2003,187,:1
18Phase Ⅰ clinical evaluation of AZD2171 in combination with ge fitinib in patients with advanced tumors显示文摘Van CRUIJSEN H VOEST E E Van HERPEN CML 2005J Clin Oncol2005,,19:1
19Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours显示文摘VAN CRUIJSEN H VOEST EE PUNT C J 2010Eur J Cancer2010,46,5:1
20Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir显示文摘 Van Cruijsen H Brown RA 2003J Infect Dis2003,187,11:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费